Key Record Dates
ClinicalTrials.gov Identifier: | NCT02142868 |
---|---|
Brief Title: | Expanded Access Study Of Palbociclib (PD-0332991) In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR-Positive, Her2-Negative Advanced Breast Cancer For Whom Letrozole Therapy Is Deemed Appropriate |
First Submitted : | May 16, 2014 |
First Submitted that Met QC Criteria : | May 16, 2014 |
First Posted : | May 20, 2014 (Estimate) |
Last Update Submitted that Met QC Criteria : | December 20, 2018 |
Last Update Posted : | December 21, 2018 |